Pușcașu Ciprian, Zanfirescu Anca, Negreș Simona
Faculty of Pharmacy, "Carol Davila" University of Medicine and Pharmacy, Traian Vuia 6, 020956 Bucharest, Romania.
Gels. 2023 May 16;9(5):417. doi: 10.3390/gels9050417.
Neuropathic pain is a complex and debilitating condition that affects millions of people worldwide. While several treatment options are available, they often have limited efficacy and are associated with adverse effects. In recent years, gels have emerged as a promising option for the treatment of neuropathic pain. Inclusion of various nanocarriers, such as cubosomes and niosomes, into gels results in pharmaceutical forms with higher drug stability and increased drug penetration into tissues compared to products currently marketed for the treatment of neuropathic pain. Furthermore, these compounds usually provide sustained drug release and are biocompatible and biodegradable, which makes them a safe option for drug delivery. The purpose of this narrative review was to provide a comprehensive analysis of the current state of the field and identify potential directions for future research in the development of effective and safe gels for the treatment of neuropathic pain, ultimately improving the quality of life for patients suffering from neuropathic pain.
神经性疼痛是一种复杂且使人衰弱的病症,影响着全球数百万人。虽然有几种治疗选择,但它们的疗效往往有限,且伴有不良反应。近年来,凝胶已成为治疗神经性疼痛的一种有前景的选择。与目前市场上用于治疗神经性疼痛的产品相比,将各种纳米载体(如立方液晶和非离子表面活性剂囊泡)纳入凝胶中可形成具有更高药物稳定性且药物向组织渗透增加的药物剂型。此外,这些化合物通常能提供药物的持续释放,并且具有生物相容性和可生物降解性,这使其成为药物递送的安全选择。本叙述性综述的目的是对该领域的现状进行全面分析,并确定在开发用于治疗神经性疼痛的有效且安全的凝胶方面未来研究的潜在方向,最终改善患有神经性疼痛患者的生活质量。